As well as its needed effects, nystatin topical (the active ingredient contained in Nyamyc) may cause unwanted side effects that require medical attention.
Dermatologic side effects associated with nystatin topical (the active ingredient contained in Nyamyc) powder, cream, and ointment have included skin irritation, burning, itching, rash, eczema, and pain on application in less than  of patients.
Genitourinary side effects associated with nystatin vaginal tablets have included vaginal irritation, burning, and itching.
At least one case of severe vulvovaginitis has also been reported.
A -year-old female experienced severe vulvovaginitis while receiving intravaginal nystatin therapy for Candida glabrata infection.
She was administered nystatin vaginal tablets, , units twice daily for  days.
She returned immediately after having completed the course complaining of intense skin rash in the vulvar area accompanied by severe irritation, burning, and itching.
Therapy with a hydrocortisone cream and intramuscular betamethasone dipropionate was initiated.
A week later, she had marked improvement with clearing of the vulvovaginal erythema and edema.
Hypersensitivity side effects associated with nystatin topical (the active ingredient contained in Nyamyc) powder, cream, and ointment have included allergic reactions and allergic contact dermatitis in less than  of patients.
Stevens-Johnson syndrome has also been reported.
It is possible that some side effects of Nyamyc may not have been reported.
These can be reported to the FDA here.
Always consult a healthcare professional for medical advice.
topical cream, topical ointment, topical powder
Vaginal burning or itching not present before use of this medicine 